Non-alcoholic steatohepatitis is now called as Metabolic dysfunction associated steatohepatitis, to promote wider understanding of the disease.It includes metabolic dysfunction marked by diabetes , insulin resistance, obesity , hyperlipidemia and hypertension.
It reduces stigma around world alcohol and better understanding of underlying cause.
It is reversible in early stages with 10 %weight loss, Mediterranean diet and risk factor control.
It is a stage after fatty liver characterisied by liver inflammation and injury.If left untreated can progress to liver scaring ( fibrosis) , cirrhosis and liver cancer.
It is expected to become leading cause of cirrhosis in coming years, leaving alcoholic cirrhosis and viral ( hepatitis C and B) hepatitis behind.
Many drugs like semaglutide and Resemtirom are under trial for MASH management along with life style modification.
Do you think lifestyle modification is enough to control this silent pandemic or medicine will play a bigger role?
MBH/AB